BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2694232)

  • 1. Pre-clinical evaluation of cognition enhancing drugs.
    Schindler U
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13 Suppl():S99-115. PubMed ID: 2694232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nootropic drugs and brain cholinergic mechanisms.
    Pepeu G; Spignoli G
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13 Suppl():S77-88. PubMed ID: 2694231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental study of the effects of amiridin and tacrine on learning and memory].
    Burov IuV; Robakidze TN; Kadysheva LV; Sukhanova SA
    Biull Eksp Biol Med; 1991 Jun; 111(6):612-4. PubMed ID: 1893185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nootropic drugs and aging.
    Giurgea CE; Greindl MG; Preat S
    Acta Psychiatr Belg; 1983; 83(4):349-58. PubMed ID: 6660010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cholinergic effects of nootropics].
    Funk KF; Schmidt J
    Biomed Biochim Acta; 1988; 47(4-5):417-21. PubMed ID: 3149192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between psychological and pharmacological treatment in cognitive impairment.
    Deberdt W
    Life Sci; 1994; 55(25-26):2057-66. PubMed ID: 7997065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing cognition through pharmacological and environmental interventions: Examples from preclinical models of neurodevelopmental disorders.
    Morè L; Lauterborn JC; Papaleo F; Brambilla R
    Neurosci Biobehav Rev; 2020 Mar; 110():28-45. PubMed ID: 30981451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of nootropics on memory: new aspects for basic research.
    Mondadori C; Petschke F; Häusler A
    Pharmacopsychiatry; 1989 Oct; 22 Suppl 2():102-6. PubMed ID: 2690149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choline alphoscerate (alpha-glyceryl-phosphoryl-choline) an old choline- containing phospholipid with a still interesting profile as cognition enhancing agent.
    Traini E; Bramanti V; Amenta F
    Curr Alzheimer Res; 2013 Dec; 10(10):1070-9. PubMed ID: 24156263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a new cognition enhancer, alpha-glycerylphosphorylcholine, on scopolamine-induced amnesia and brain acetylcholine.
    Lopez CM; Govoni S; Battaini F; Bergamaschi S; Longoni A; Giaroni C; Trabucchi M
    Pharmacol Biochem Behav; 1991 Aug; 39(4):835-40. PubMed ID: 1662399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognition Enhancing Activity of Sulforaphane Against Scopolamine Induced Cognitive Impairment in Zebra Fish (Danio rerio).
    Rajesh V; Ilanthalir S
    Neurochem Res; 2016 Oct; 41(10):2538-2548. PubMed ID: 27255600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between the behavioral effects of cognition-enhancing drugs and brain acetylcholine. Nootropic drugs and brain acetylcholine.
    Pepeu G; Spignoli G; Giovannini MG; Magnani M
    Pharmacopsychiatry; 1989 Oct; 22 Suppl 2():116-9. PubMed ID: 2602443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can the pattern of neuropsychological improvement obtained with cholinergic drugs be used to infer a cholinergic mechanism in other nootropic drugs?
    Gainotti G; Nocentini U; Sena E
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13 Suppl():S47-59. PubMed ID: 2694229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nootropic effects of ACE inhibitors in mice.
    Mondadori C; Etienne P
    Psychopharmacology (Berl); 1990; 100(3):301-7. PubMed ID: 2138337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The families of cognition enhancers.
    Fröstl W; Maître L
    Pharmacopsychiatry; 1989 Oct; 22 Suppl 2():54-100. PubMed ID: 2690152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacological analysis of memory disorders of different origins].
    Rakhmankulova IKh; Voronina TA
    Biull Eksp Biol Med; 1989 Jun; 107(6):697-9. PubMed ID: 2571367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of scopolamine-induced amnesia and alterations in energy metabolism by the nootropic piracetam: implications regarding identification of brain structures involved in consolidation of memory traces.
    Piercey MF; Vogelsang GD; Franklin SR; Tang AH
    Brain Res; 1987 Oct; 424(1):1-9. PubMed ID: 3690290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ethanolic extract of the Eclipta prostrata L. ameliorates the cognitive impairment in mice induced by scopolamine.
    Jung WY; Kim H; Park HJ; Jeon SJ; Park HJ; Choi HJ; Kim NJ; Jang DS; Kim DH; Ryu JH
    J Ethnopharmacol; 2016 Aug; 190():165-73. PubMed ID: 27267831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of piracetam's anti-amnesic activity in three models of amnesia in the mouse.
    Lenègre A; Chermat R; Avril I; Stéru L; Porsolt RD
    Pharmacol Biochem Behav; 1988 Mar; 29(3):625-9. PubMed ID: 3362958
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.